Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion

Movement Disorders

Volumn 28, Issue 6, 2013, Pages 840-841

  Cannas, Antonino ^a   Solla, Paolo ^a   Marrosu, Maria Giovanna ^a   Marrosu, Francesco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBIDOPA PLUS LEVODOPA; DOPAMINE; ESCITALOPRAM; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE;

ADULT; AGED; CASE REPORT; CYCLOTHYMIC AFFECTIVE SYNDROME; DELUSIONAL DISORDER; DEPRESSION; DISEASE DURATION; DOPAMINE DYSREGULATION SYNDROME; DRUG EFFICACY; DYSKINESIA; DYSPHORIA; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOMANIA; INSOMNIA; LETTER; MAINTENANCE DRUG DOSE; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; PARANOID PSYCHOSIS; PARKINSON DISEASE; PERSECUTORY DELUSION; PRIORITY JOURNAL; REMISSION; SOCIAL INTERACTION;

ABNORMALITIES, DRUG-INDUCED; ADULT; AGED; ANTIPARKINSON AGENTS; DOPAMINE; DUODENUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE;

EID: 84879598999     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25508     Document Type: Letter

References (7)

1. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-428.
2. Gerschlager W, Bloem BR. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions. Mov Disord 2009;24:1858-1860.
3. Pålhagen SE, Dizdar N, Hauge T, et al. Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease. Acta Neurol Scand 2012;126:e29-e33.
4. Zibetti M, Merola A, Ricchi V, et al. Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study. J Neurol 2013;260:105-114.
5. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006;59:852-858.
6. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003;2:595-604.
7. Katzenschlager R. Dopaminergic dysregulation syndrome in Parkinson's disease. J Neurol Sci 2011;310:271-275.